Explore More View

Many patients with breast cancer have expressed heartfelt gratitude and created special bonds with Julie Margenthaler, MD, FACS, director of Breast Surgical Services at Siteman Cancer Center. While her expert surgical oncology skills are nationally renowned, patients especially appreciate her compassionate, personal approach to care.

In honor of her dedication to patients over the past 30 years, Dr. Margenthaler was installed as the inaugural Endowed Chair for Surgical Excellence in Breast Cancer through The Foundation for Barnes-Jewish Hospital on April 9, 2026.

A total of 16 research scientists and physicians received support from the Siteman Investment Program (SIP). SIP is a biannual research grant program at Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine. These individuals are leading unique cancer research projects that advance patient care through innovation.

The Foundation for Barnes-Jewish Hospital is pleased to announce it has raised $2 million to establish PREVENT, a multidisciplinary program at WashU Medicine and Barnes-Jewish Hospital focused on prevention and early detection of stomach and pancreatic cancers.

Inflammatory breast cancer (IBC) is a rare but highly aggressive cancer that progresses very quickly, often over the course of days or weeks.

Thanks to ongoing donor support through The Foundation for Barnes-Jewish Hospital, WashU Medicine researchers are making progress on better ways to tackle triple-negative breast cancer (TNBC).